Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ... [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
AUSTEDO Revenue: $435 million, 28% growth. AJOVY Revenue: 21% growth. UZEDY Revenue: $35 million in Q3, year-to-date $75 million. Global Generics Growth: 17% increase. TAPI Growth: 4% increase. Non-GAAP Gross Profit Margin: Non-GAAP Operating Margin: Non-GAAP EPS: Net Debt: $15.7 billion. Net Debt to EBITDA Ratio: 3x. 2024 Revenue Guidance: Raised to $16.1 billion to $16.5 billion. 2024 EPS Guidance: Raised to $2.40 to $2.50. Warning! GuruFocus has detected 5 Warning Signs with TEVA. Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Teva Pharmaceutical Industries Ltd ( NYSE:TEVA ) reported a 15% increase in revenues, reaching $4.3 billion for Q3 2024. The company's innovative products, AUSTEDO, AJOVY, and UZEDY, showed strong performance with growth rates of 28%, 21%, and a successful launch, respectively. Teva's global generics business grew by 17%, with significant co
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025GlobeNewswire
- My Top 10 Portfolio Holdings for 2025 [Yahoo! Finance]Yahoo! Finance
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $25.00 to $28.00. They now have an "overweight" rating on the stock.MarketBeat
- Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength? [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 11/6/24 - Beat
TEVA
Sec Filings
- 12/20/24 - Form 144
- 12/4/24 - Form 4
- 12/4/24 - Form 3
- TEVA's page on the SEC website